| Name | Title | Contact Details |
|---|
High-performing pharmacy is who we are At Visante, we believe in moving healthcare forward through innovative solutions that deliver lasting results. For over 20 years, we`ve been advancing the business of pharmacy™ by helping our clients deliver compliant services and products that foster growth and improve patient care. Our firm focuses on three areas of medication management: hospitals and health systems, pharmaceutical industry and managed care/government programs. Integrated health networks (IDNs), hospitals and health systems know us for our expertise to maximize lasting growth in 340B programs, specialty pharmacy, pharmacy assessments, sterile compounding and drug diversion. In addition, through our partner PharmacyStars, we provide a platform of technology solutions for our hospital and health system clients to maximize compliance in the areas of 340B, sterile compounding, drug diversion and more. Our managed care and government programs experts are here to help you navigate complex, changing requirements to reach compliance goals. Specializing in Medicare Parts C and D consulting, we can help you prepare for audits by the Centers for Medicare and Medicaid Services (CMS), conduct mock audits, improve operations, and maintain compliance. No matter how complex your compliance issues and operational needs are, we`re here to implement quality, cost-effective solutions. Visante consists of more than 60 consultants across the U.S., Canada, and the U.K., all working together to provide expert guidance from a wide range of disciplines, including pharmacy, nursing, operations, and information technology. We`re here to move the practice of pharmacy in the right direction.
Laurels Of Norworth is a Worthington, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Educational Resource Systems is a Red Bank, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
ETEK Services is a Fort Lauderdale, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Voyager Therapeutics is developing life-changing gene therapies from discovery, preclinical and clinical development, through to commercialization. We focus on people living with severe neurological diseases that lack safe and effective treatment options, particularly in the areas of Parkinson`s disease, monogenic forms of amyotrophic lateral sclerosis (ALS), Friedreich`s ataxia, Huntington`s disease, Alzheimer`s Disease and other tau-related neurodegenerative diseases, and severe, chronic pain. We are also committed to advancing the field of AAV (adeno-associated virus) gene therapy through innovation and investment in vector engineering and optimization, dosing techniques, as well as process development and production. Our management team and founders represent some of the most esteemed scientific and clinical leaders in the fields of AAV gene therapy, expressed RNA interference, neuroscience preclinical and clinical development, and manufacturing. We have broad strategic collaborations with Genzyme, a Sanofi company, AbbVie and the University of Massachusetts Medical School (UMMS). We have also entered into license and other agreements with UMMS, the University of California San Francisco and Stanford University to access relevant technology and data.